Göran Möller

Q: What Schools Are Affiliated With Göran Möller

Göran Möller is affiliated with the following schools: Stockholm University, Karolinska Institute

Göran Möller's AcademicInfluence.com Rankings

Göran Möller

Biology

#4497

World Rank

#6698

Historical Rank

Immunology

#195

World Rank

#204

Historical Rank

biology Degrees

Download Badge

Biology

Göran Möller's Degrees

Masters Biotechnology Uppsala University
Bachelors Biology Stockholm University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Göran Möller Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Göran Möller's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Regulatory effect of antibody on the immune response. (1968) (603)
DEMONSTRATION OF MOUSE ISOANTIGENS AT THE CELLULAR LEVEL BY THE FLUORESCENT ANTIBODY TECHNIQUE (1961) (388)
Selective induction of DNA synthesis in T and B lymphocytes. (1972) (376)
Thymus-independent B-cell induction and paralysis. (1975) (291)
B cell mitogenic properties of thymus-independent antigens. (1973) (231)
Immune Activation of B Cells: Evidence for‘One Nonspecific Triggering Signal' Not Delivered by the Ig Receptors (1974) (225)
Mitogens as Probes for Immunocyte Activation and Cellular Cooperation (1972) (223)
MECHANISM OF THYMUS-INDEPENDENT IMMUNOCYTE TRIGGERING (1974) (223)
Do Suppressor T Cells Exist? (1988) (213)
Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. (1968) (209)
ANTIBODY SYNTHESIS AT THE CELLULAR LEVEL. ANTIBODY-INDUCED SUPPRESSION OF 19S AND 7S ANTIBODY RESPONSE. (1965) (186)
Activation of B lymphocytes by locally concentrated concanavalin A (1972) (177)
Simultaneous production of interleukin 2, interleukin 4 and interferon‐γ by activated human blood lymphocytes (1990) (169)
Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. (2002) (159)
Specificiy of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells. (1972) (148)
QUANTITATIVE STUDIES OF THE SENSITIVITY OF NORMAL AND NEOPLASTIC MOUSE CELLS TO THE CYTOTOXIC ACTION OF ISOANTIBODIES (1962) (138)
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. (1968) (137)
Frequency of antigen-sensitive cells to thymus-independent antigens. (1971) (129)
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro (1972) (128)
In vitro activation of mouse lymphocytes in serum‐free medium: effect of T and B cell mitogens on proliferation and antibody synthesis (1973) (126)
Interleukin 4 instructs uncommitted B lymphocytes to switch to IgGl and IgE (1988) (123)
Cyclosporin A blocks receptors for HLA-DR antigens on T cells (1981) (121)
Characterization of self-reactive B cells by polyclonal B-cell activators (1977) (112)
Differentiation of B Cells: Sequential Appearance of Responsiveness to Polyclonal Activators (1974) (110)
19S Antibody Production against Soluble Lipopolysaccharide Antigens by Individual Lymphoid Cells In Vitro (1965) (103)
Effect on Tumour Growth in Syngeneic Recipients of Antibodies Against Tumour-Specific Antigens in Methylcholanthrene-Induced Mouse Sarcomas (1964) (102)
Induction of DNA synthesis in human lymphocytes: interaction between non-specific mitogens and antigens. (1970) (97)
EFFECT OF B-CELL MITOGENS ON LYMPHOCYTE SUBPOPULATIONS POSSESSING C'3 AND Fc RECEPTORS (1974) (95)
B lymphocytes can be stimulated by concanavalin A in the presence of humoral factors released by T cells (1972) (93)
Immune Response in Deep Cervical Lymph Nodes and Spleen in the Mouse after Antigen Deposition in Different Intracerebral Sites (1988) (93)
Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes. (1969) (92)
Suppressive effect of graft versus host reactions on the immune response to heterologous red cells. (1971) (91)
Molecular Basis of B‐Cell Activation (1974) (89)
In vitro effects of HgCl2 on murine lymphocytes. I. Preferable activation of CD4+ T cells in a responder strain. (1995) (88)
Immunological and Immunogenetic Aspects of Tumor Transplantation (1965) (87)
The Role of Adherent Cells in B and T Lymphocyte Activation (1978) (86)
Induction of autoantibodies to red blood cells by polyclonal B-cell activators (1976) (83)
T cell clones (1981) (82)
Requirement for adherent cells in the primary and secondary immune response in vitro (1972) (81)
GENERATION OF CYTOTOXIC LYMPHOCYTES IN MIXED LYMPHOCYTE REACTIONS I. SPECIFICITY OF THE EFFECTOR CELLS (1973) (79)
Inhibition of In Vitro Immune Responses by a Fraction from Seminal Plasma (1976) (79)
Lipopolysaccharides can convert heterologous red cells into thymus-independent antigens. (1972) (78)
HLA-DR antigens render resting T cells sensitive to interleukin-2 and induce production of the growth factor in the autologous mixed lymphocyte reaction. (1981) (75)
Studies on the Mechanism of Immunological Enhancement of Tumor Homografts. 1. Specificity of Immunological Enhancement (1963) (74)
Polyclonal Antibody Secretion in Human Lymphocytes Induced by Killed Staphylococcal Bacteria and by Lipopolysaccharide (1977) (71)
B lymphocyte activation. (1981) (71)
REGULATION OF CELLULAR ANTIBODY SYNTHESIS (1968) (71)
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen (1976) (69)
Prolonged survival of H-2 incompatible skin allografts on F1 animals treated with parental lymphoid cells. (1969) (64)
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. (1970) (61)
Role of C'3 and Fc receptors in B-lymphocyte activation (1975) (61)
The Polyclonal B‐Cell‐Activating Property of Protein A Is Not Due to Its Interaction with the Fc Part of Immunoglobulin Receptors (1977) (60)
Immunological unresponsiveness to native dextran B512 in young animals of dextran high responder strains is due to lack of Ig receptors expression. Evidence for a nonrandom expression of V-genes (1978) (59)
Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB × NZW)F1 hybrids (1996) (58)
Concomitant production of different lymphokines in activated T cells (1988) (58)
Enumeration of IFN-?-producing cells by flow cytometryComparison with fluorescence microscopy (1988) (58)
Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures. (1972) (57)
Mitogenic properties of the thymus‐independent antigen pneumococcal polysaccharide siii (1973) (55)
The Concept of Immunological Surveillance against Neoplasia (1976) (54)
Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity. (1975) (53)
Mitogen‐induced lymphocyte‐mediated cytotoxicity in vitro: Effect of mitogens selectively activating T or B cells (1972) (53)
HLA and disease susceptibility. (1983) (50)
Studies on the mechanism of immunological enhancement of tumor homografts. III. Interaction between humoral isoantibodies and immune lymphoid cells. (1963) (50)
Persistence of immunogenicity of two complex antigens retained in vivo. (1968) (50)
Regulation of IgG1 and IgE Synthesis by Interleukin 4 in Mouse B Cells (1989) (49)
Plaque-Formation by Non-Immune and X-Irradiated Lymphoid Cells on Monolayers of Mouse Embryo Cells (1965) (48)
Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells. (1970) (48)
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. (1969) (47)
T cell stimulating growth factors. (1980) (47)
Influence of RU 41.740, a glycoprotein extract from Klebsiella pneumoniae, on the murine immune system. I. T-independent polyclonal B cell activation. (1984) (43)
INTERACTION BETWEEN ALLOGENEIC CELLS IN TISSUE TRANSPLANTATION * (1966) (43)
in vitro induction of specific immune responses in the absence of serum: requirement for nonspecific t or b cell mitogens (1973) (42)
Quantitation of the number of mitogen molecules activating DNA synthesis in T and B lymphocytes. (1973) (42)
Interleukins and lymphocyte activation. (1982) (41)
Considerations of some current concepts in cancer research. (1975) (41)
Contribution of H-2 and non-H-2 genes in the control of mercury-induced autoimmunity. (2000) (41)
The Effector Cell in Antibody‐Induced Cell Mediated Immunity (1973) (41)
Antibody‐mediated suppression of the immune response is determinant specific (1985) (40)
Antigen-induced strain-specific autoantiidiotypic antibodies modulate the immune response to dextran B 512. (1979) (39)
The Immune Response to the Alpha 1–6 Epitope of Dextran is Determined by a Gene Linked to the IgCH Locus (1979) (39)
Regulation of cellular antibody synthesis effect of adoptively transferred antibody-producing spleen cells on cellular antibody synthesis. (1968) (39)
Studies on the Mechanism of Immunological Enhancement of Tumor Homografts. 11. Effect of Isoantibodies on Various Tumor Cells (1963) (39)
Immunological Tolerance Affects Only a Subpopulation of the Antigen‐Specific B Lymphocytes: Evidence against Clonal Deletion as the Mechanism of Tolerance Induction (1979) (38)
Characterization of individual tumor necrosis factor α- and β-producing cells after polyclonal T cell activation (1989) (38)
Polyclonal B-cell activators induce immunological response to autologous serum proteins. (1977) (38)
Effect of PPD on the specific immune response to heterologous red cells in vitro. (1974) (37)
Studies at the cellular level of the 19S immune response. (1966) (37)
The Role of Adherent Cells in the Immune Response (1976) (37)
Helper interleukins are produced by both CD4 and CD8 splenic T cells after mitogen stimulation (1991) (36)
In Vitro Destruction of Human Fibroblasts by Non-Immune Lymphoid Cells (1966) (36)
Hybrid myeloma monoclonal antibodies against MHC products (1979) (34)
Reversibility of high dose unresponsiveness to concanavalin A in thymus lymphocytes. (1972) (34)
Role of macrophages in the immune response. (1978) (34)
Effects of anti-immunoglobulin sera on B lymphocyte functions. (1978) (33)
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. (1970) (32)
Studies on the Development of the Isoantigens of the H-2 System in Newborn Mice (1961) (32)
Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB x NZW)F1 hybrid. (1992) (31)
Macrophage depletion decreases IgG anti‐DNA in cultures from (NZB · NZW)F1 spleen cells by eliminating the main source of IL‐6 (1993) (31)
Antibody carriers of drugs and toxins in tumor therapy. (1982) (30)
Immunogenicity, tolerogenicity, and mitogenicity of lipopolysaccharides. (1973) (30)
Acquisition of the T cell repertoire (1978) (30)
Mechanism of B‐Lymphocyte Activation: Failure to Obtain Evidence of a Direct Role of the Ig Receptors in the Triggering Process (1975) (29)
Manipulation of the superantigen‐induced lymphokine response. Selective induction of interleukin‐10 or interferon‐γ synthesis in small resting CD4+ T cells (1993) (28)
Reconstitution of immunocompetence in B cells by addition of concanavalin A or concanavalin A-treated thymus cells. (1973) (28)
The immune response to infectious diseases (1974) (28)
Carrageenans, highly sulfated polysaccharides and macrophage-toxic agents: newly found human T lymphocyte mitogens. (1982) (28)
In vitro detection of transplantation immunity: the inhibition of migration of immune spleen cells and peripheral blood leukocytes by specific antigen. (1970) (28)
A Primary Immune Response to Dextran B512 is Followed by a Period of Antigen‐specific Immunosuppression Caused by Autoanti‐idiotypic Antibodies (1980) (27)
Induction of antigenic competition with thymus-dependent antigens: effect on DNA synthesis in spleen cells. (1971) (27)
Autoantibody formation after bone marrow transplantation. Comparison between acetylcholine receptor antibodies and other autoantibodies and analysis of HLA and Gm markers. (1989) (26)
Concanavalin‐A‐Activated Lymphocytes Suppress Immune Responses in Vitro but Are Helper Cells in Vivo (1985) (26)
Immune Response to Haptenated Syngeneic and Allogeneic Lymphocytes (1978) (26)
Immunological Tolerance to the Thymus‐Independent Antigen Dextran can be Abrogated by Thymus‐Dependent Dextran Conjugates: Evidence against Clonal Deletion as the Mechanism of Tolerance Induction (1978) (26)
Polymyxins as inhibitors of polyclonal B-cell activators in murine lymphocyte cultures (1977) (25)
Pretreatment of lymphocytes with mercury in vitro induces a response in T cells from genetically determined low‐responders and a shift of the interleukin profile (1997) (25)
Immunological and Immunogenetic Aspects of Tumor Transplantation (Part 1 of 3) (1965) (25)
Major histocompatibility complex class II antigens are required for both cytokine production and proliferation induced by mercuric chloride in vitro. (1997) (24)
Influence of RU 41.740, a glycoprotein extract from Klebsiella pneumoniae, on the murine system. II. RU 41.740 facilitates the response to Con A in otherwise unresponsive T-enriched cells. (1985) (23)
Cytotoxicity of Human Lymphocytes: Antagonism between Inducing Processes (1968) (23)
ANTIBODY SYNTHESIS AT THE CELLULAR LEVEL (1965) (23)
Lymphocyte-activating factors released in vitro by sensitized and nonsensitized human lymphocytes. (1970) (23)
Mechanism of B‐Cell Activation and Paralysis by Thymus‐Independent Antigens (1975) (22)
T and B cell collaboration: induction of motility in small, resting B cells by interleukin 4 (1991) (22)
Biologic properties of 19 S and 7 S mouse isoantibodies directed against isoantigens of the H-2 system. (1966) (22)
Irreversible Immunological Tolerance to Thymus‐independent Antigens is Restricted to the Clone of B Cells having both Ig and PBA Receptors for the Tolerogen (1978) (22)
Serum antibody and cellular immune response in mice to dextran B512. (1990) (21)
In vitro effects of HgCl2 on murine lymphocytes. II. Selective activation of T cells expressing certain V beta TCR. (1996) (21)
Subclass restriction pattern of antigen-specific antibodies in donors with defective expression of IgG or IgA subclass heavy chain constant region genes. (1987) (21)
Immunocompetent cells in graft rejection. (1971) (20)
Mechanism of B-cell activation and self-non-self discrimination. (1977) (20)
Induction of immunological tolerance requires that the B cells can respond to the polyclonal B-cell-activating properties of the thymus- independent antigens (1977) (20)
Antigen-induced suppression of the in vitro lymphocyte response to different antigens and mitogens. (1972) (20)
Enumeration of IFN-gamma-producing cells by flow cytometry. Comparison with fluorescence microscopy. (1988) (20)
Detection of Individual Interleukin 4‐ and Gamma Interferon‐Producing Murine Spleen Cells after Activation with T‐Cell Mitogens (1989) (19)
Phenotypic Expression of Isoantigens of the H-2 System in Embryonic and Newborn Mice (1963) (19)
Genetic Control of Resistance to Mercury‐Induced Immune/Autoimmune Activation (2001) (19)
Bacterial Lipopolysaccharides Bind Selectively to Lymphocytes from Lipopolysaccharide High‐responder Mouse Strains (1979) (18)
Cytotoxic T-cell activation by polyribonucleotides: DNA synthesis is not required (1977) (18)
Con‐A‐activated T Cells Secrete Factors with Polyclonal B‐Cell‐activating Properties (1979) (18)
PROLONGED SURVIVAL OF ALLOGENEIC: (HOMOLOGOUS) NORMAL TISSUES IN ANTISERUM‐TREATED RECIPIENTS (1964) (18)
Evidence for the existence of self-reactive human B lymphocytes. (1977) (18)
Mercury-induced anti-nucleolar autoantibodies can transgress the membrane of living cells in vivo and in vitro. (1999) (17)
STUDIES IN VITRO AND IN VIVO OF THE CYTOTOXIC AND ENHANCING EFFECT OF HUMORAL ISOANTIBODIES * (1962) (17)
Experimental conditions for obtaining suppressor and helper effects on the primary in vitro immune response by lymphocytes activated by polyclonal T-cell activators (1977) (17)
Frequencies of interleukin‐5 mRNA‐producing cells in healthy individuals and in immunoglobulin‐deficient patients, measured by in situ hybridization (1990) (17)
Immune responses to xanthan gum I. The characteristics of lymphocyte activation by xanthan gum (1983) (17)
B cell differentiation antigens (1983) (16)
Mercury‐induced renal immune complex deposits in young (NZB × NZW)F1 mice: characterization of antibodies/autoantibodies (1997) (16)
Mitogenic response of mouse spleen cells and gelation of limulus lysate by lipopolysaccharide of Yersinia pestis and evidence for neutralization of lipopolysaccharide by polymyxin B (1977) (15)
Lithium chloride induces partial responsiveness to LPS in nonresponder B cells (1982) (15)
CD8+ Cells are the Main Producers of IL10 and IFNγ after Superantigen Stimulation (1996) (15)
A Thymus‐independent IgG Response against Dextran B512 can be Induced in C57BL but not in CBA Mice, even though both Strains Possess a VHdex Gene (1979) (15)
Mercury-induced renal immune complex deposits in young (NZB x NZW)F1 mice: characterization of antibodies/autoantibodies (1997) (15)
The Immunoglobulin Receptors on B Cells Bind Antigen, Focus Activation Signals to Them and Initiate Antigen‐Presentation (1991) (15)
Activation of antibody synthesis in human B lymphocytes (1979) (14)
Regulation of cellular antibody synthesis. Selective suppression by antibody of the immune response induced by a high antigen dose. (1969) (14)
Suppression of the immune response to altered self induced by immunogenic and nonimmunogenic altered self structures (1980) (14)
Mechanism of Action of Suppressor Cells (1977) (14)
Differential effect of heterologous anti-lymphocyte serum on antibody-producing cells and antigen-sensitive cells. (1968) (14)
Immunoglobulin D : structure, synthesis, membrane representation and function (1977) (14)
Off‐Signals in Lymphocyte Activation (1976) (14)
Concanavalin A Inhibits the Effector Phase of Specific Cytotoxicity (1982) (13)
Phenotypic expression of mouse isoantigens. (1962) (13)
Cyclosporin A Inhibits Thymus‐dependent but not Thymus‐independent Immune Responses Induced by Dextran B512 (1982) (13)
The Effects of Interleukins 4 and 5 on the Differentiation of B Cells from (NZB × NZW)F1 Mice (1991) (13)
FACTORS INFLUENCING ACTIVATION OF B‐CELLS IN IMMUNITY * (1975) (13)
Sera from lipopolysaccharide (LPS)-injected mice exhibit complement-dependent cytotoxicity against syngeneic and autologous spleen cells. (1977) (13)
Structure and function of HLA-DR. (1982) (13)
Interferon‐γ and growth factor production by murine T cells derived from three different lymphoid tissues (1991) (12)
Fractionation of immunocompetent spleen cells by albumin density gradient centrifugation. (1970) (12)
Precipitin and mitogenic behavior of dimeric and tetrameric concanavalin A (1975) (12)
In vitro correlates of transplantation immunity: the release of substances by immune lymphocytes confronted with specific antigens. (1969) (12)
Regulation of In Vitro Immunocyte Activation (1977) (12)
Induction of Immunity and Suppression by Haptenated Self Structures (1980) (12)
The antibody spectrum in individuals with defect expression of HLA class II and the LFA-1 glycoprotein family genes. (1988) (12)
Functional T cell subsets defined by monoclonal antibodies (1983) (12)
Differential regulation of lymphokine production in mitogen‐stimulated murine spleen cells (1991) (11)
Release of Migration Inhibitory Factors from Immune Rat Lymphocytes confronted with Histocompatibility Antigens (1969) (11)
Interleukin-10 inhibits motility in murine and human B lymphocytes. (1994) (11)
Lipopolysaccharide‐stimulated events in B Cell Activation (1994) (11)
The Fc Binding Regions in Protein A are not Responsible for the Polyclonal B Cell Activating Property of Protein A (1979) (11)
Survival of Mouse Erythrocytes in Histoincompatible Recipients (1963) (11)
Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. (1974) (11)
Immune response against two epitopes on the same thymus-independent polysaccharide carrier. 1. Role of epitope density in carrier-dependent immunity and tolerance. (1977) (10)
Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo. (1974) (10)
The immune response against two epitopes on the same thymus-independent polysaccharide carrier. II. Enhanced anti-hapten responses by injection of the unconjugated carrier. (1977) (10)
Rapid lymphocytic recognition of histoincompatibility. Changes of the deoxyribonucleoprotein complex in mixed cultures of allogeneic human lymphocytes. (1970) (10)
The cytotoxic effect of antigenic and/or structural incompatibility in vitro. (1965) (10)
Isoantibody-Induced Cellular Resistance to Immune Hæmolysis in vivo and in vitro (1964) (10)
Thymus‐Independent B‐Cell Activation: Passively Incorporated Membrane Antibodies Serve to Focus the Antigen but Cannot Transmit Activation Signals (1990) (10)
The Influence of T Cells on the Immunoglobulin Repertoire and the Affinity Maturation of the Immune Response Against Dextran B512 in C57BL/6 Mice (1991) (9)
Accessory cells in the immune response (1980) (9)
Effects of anti-membrane antibodies on killer T cells. (1982) (9)
Effect of Polyclonal B‐Cell Activators on DNA Synthesis in Fibroblasts (1975) (9)
Lymphocyte‐Mediated Cytotoxicity Against Tumor Cells Specificity and Characterization of Concanavalin A‐Activated Cytotoxic Effector Lymphocytes (1976) (9)
Antigen–Antibody Complex‐Induced Immunosuppression (1988) (9)
IL-2 may be a limiting factor precluding lymphocytes from genetically resistant mice from responding to HgCl2. (1999) (9)
Immunological unresponsiveness of self-recognizing B lymphocytes to the PBA property of a soluble T cell factor. (1978) (9)
Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation. (1989) (8)
Ir genes and T lymphocytes (1978) (8)
The IgE Receptor (1981) (8)
Binding characteristics of aggregated IgGa to rat basophilic leukaemia (RBL) cells and rat mast cells. (1980) (8)
Rheumatoid Synovial Fluid Reconstitutes the B‐Cell Defect in CBA/N Mice (1989) (8)
Inhibition of tumor growth by confrontation with incompatible cells. Possible surveillance mechanism against neoplasia (1967) (8)
Immunology of feto-maternal relationship (1983) (8)
The effect of T cell-derived cytokines on B cell motility in vitro. (1993) (7)
Functional Heterogeneity of Splenic T Lymphocyte Subpopulations I. Determination of Splenic Subpopulations by the Use of Mitogenic Probes (1977) (7)
The allogeneic effect in vitro: activation of antibody synthesis in aggressor and target lymphocyte populations by allogeneic interaction (1973) (7)
Specific Antibodies are Responsible for the Low Dose Suppression of the Immune Response to Thymus‐Independent Antigens (1978) (7)
Capping and Co‐Capping of Membrane Immunoglobulin and Lipid‐Conjugated Immunoglobulin Inserted in the Cell Membrane of B Lymphocytes (1989) (7)
Experiments and the concept of immunological surveillance (1976) (7)
Ontogeny of human lymphocyte function. (1981) (7)
Unresponsiveness of CD4+ T Cells from a Non‐Responder Strain to HgCl2 is Not Due to CD8+‐Mediated Immunosuppression: an Analysis of the Very Early Activation Antigen CD69 (1996) (7)
Unresponsiveness to haptenated self molecules (1980) (6)
Heterologous antilymphocyte serum: differential effect on antigen-sensitive and antibody-producing cells. (1968) (6)
Presence of Alloantigen‐Reactive Cells in Neonatally Tolerized Mice (1978) (6)
Ontogenic Development of the Suppressed Secondary Response to Native Dextran (1982) (6)
CELLULAR ASPECTS OF IMMUNOLOGICAL TOLERANCE TO E. COLI LIPOPOLYSACCHARIDES * (1971) (6)
An in vitro test of the immunosuppressive activity of antilymphocyte serum. (1970) (6)
Partial Biochemical Characterization and Purification of IgG2b Inducing Factor as a New Cytokine from Synovial Fluid of Patients with Rheumatoid Arthritis (1993) (5)
Immunological surveillance against neoplasia (1978) (5)
Immunology and differentiation (1977) (5)
Antigen Processing and Presentation by Small and Large B Cells (1991) (5)
Antibody‐coated Sheep Erythrocytes Suppress the Ability of Polyclonal B‐Cell Activators to Induce Plaque‐forming Cells against Sheep Erythrocytes (1980) (5)
GENERATION OF CYTOTOXIC LYMPHOCYTES IN MIXED LYMPHOCYTE REACTIONS (1973) (5)
Lipopolysaccharide as a tool to reveal autoreactive B cells (1988) (5)
Biology of complement and complement receptors (1976) (5)
Mechanism of B Lymphocyte Activation (1979) (4)
Trypsin Does Not Reconstitute Responsiveness to Lipopolysaccharide in the Strain C3H/HeJ, but Is a B‐Cell Mitogen‐Like Lipopolysaccharide, Stimulating a Different Subpopulation (1989) (4)
Membrane‐Incorporated Immunoglobulin Receptors Increase the Antigen‐Presenting Ability of B Cells (1991) (4)
ELISA Assay for the Detection of a Dextran‐Binding Product Secreted by a T‐Cell Hybrid Th 1 (1987) (4)
Reactivity of human lymphocytes to aggregated and nonaggregated PPD-tuberculin. (1972) (4)
Mechanism of action of cytotoxic T-cells (1983) (4)
SIGNALS AND RECEPTORS IN B CELL ACTIVATION (1975) (4)
Autoimmunity and self-nonself discrimination (1976) (4)
Genetic models of B cell differentiation. (1982) (4)
HLA-DR antigens induce proliferation and cytotoxicity of T cells against haptenated (TNP and FITC) self structures (2004) (4)
Forced Contact between Antigen‐Presenting Cells and T Cells: Consequences for T‐Cell Activation (1989) (3)
Elimination of allogeneic lymphoid cells (1983) (3)
Commitment to Lymphokine Profile During Primary In Vitro Stimulation (1993) (3)
MHC restriction of anti-viral immunity. (1981) (3)
Antibody suppression of gene products (1975) (3)
Role of Fc receptor bearing T cells (1981) (3)
THE DEGREE OF CLONAL ELIMINATION IN VARIOUS TYPES OF SPECIFIC IMMUNOLOGICAL UNRESPONSIVENESS (1982) (3)
Increasing the efficiency of lipid-conjugated antibodies incorporation into the membrane of antigen presenting B cells. (1992) (3)
Current Concepts of the Mechanisms of Antibody Suppression are not Compatible with Contemporary Knowledge of Lymphocyte Activation (2001) (3)
Binding parameters of defined immune complexes to rat basophilic leukaemia (RBL) cells. (1981) (3)
Qualitative Shift of Lymphokine Production in Response to Stimulation, as a Consequence of Preactivation In Vivo or In Vitro (1992) (3)
SURVIVAL OF H-2 INCOMPATIBLE MOUSE ERYTHROCYTES IN UNTREATED AND ISOIMMUNE RECIPIENTS. (1965) (3)
T cell hybrids (1983) (3)
Conditions for T cell activation (1977) (3)
Tumor associated embryonic antigens (1974) (3)
Regulation of the immune response by antibodies against the immunogen (1980) (3)
Components of immune recognition : detection and analysis (1974) (2)
Mechanism of B lymphocyte tolerance (1979) (2)
Interaction between Allogeneic Cells of Human Origin: an In Vitro Model for Graft Rejection (1967) (2)
Anti-IgM-Ficoll conjugates activate B cells from CBA but not CBA/N mice. (1994) (2)
Antigens: Thymus Independent (2001) (2)
Control of immunoglobulin C gene expression (1982) (2)
Membrane‐Incorporated Surrogate Receptors Increase Antigen Presentation by Resting B Cells, but not by LPS‐Activated Blasts (1993) (2)
On the secretory process of rat mast cells and rat basophilic leukaemia cells. Effects of aggregated IgGa on 45Ca influx and histamine secretion. (1983) (2)
Models of autoimmune diseases (1981) (2)
The V gene repertoire as revealed by polyclonal B cell activators. (1976) (2)
Functional role of autoantiidiotypic antibodies in the regulation of the immune response to dextran. (1986) (2)
Activation of B lymphocytes by concanavalin A in the presence of humoral factors released by T cells. (1972) (2)
Primary Stimulation of CD4+ Cells in the Presence of IL‐4 or IFN‐γ Alters the Frequencies of Cytokine‐Producing Cells at Restimulation (1992) (2)
B Cells Carrying Surrogate Receptors in their Membranes Process and Present Antigen to Specific Murine T Cells (1993) (2)
INABILITY OF NORMAL AND ACTIVATED THYMUS‐DERIVED CELLS TO ACT AS CYTOTOXIC EFFECTOR CELLS AGAINST ANTIBODY‐COATED TARGETS (1976) (2)
Experimentally Induced Transplantation Tolerance (1981) (2)
Organization of immunoglobulin genes (1981) (2)
Mechanism of unresponsiveness to the alpha 1-6 epitope of dextran B512 in a C57BL substrain (1983) (2)
Potentiation of the PFC Response to Thymus‐Independent Antigens by Heterologous Erythrocytes (1982) (2)
Lymphocyte activation by Con A. (1978) (2)
The Polyclonal B Cell Activator Dextran‐Sulphate Induces Formation of Colony Stimulating Activity (1978) (2)
[A Swedish antilymphocyteglobulin]. (1969) (1)
[The great immunological adventure is over. The important discoveries are already made]. (1988) (1)
[Homeostatic mechanisms in antibody synthesis]. (1966) (1)
Allogeneic bone marrow transplantation (1983) (1)
Contact‐Induced Cytotoxicity and its Relation to Cellular Immunity (1966) (1)
Genetic Analysis of the Low Responsiveness to Dextran B512 in CB A/N and C57BL/10ScCr Mice (1983) (1)
RAPID LYMPHOCYTE RECOGNITION OF HISTOINCOMPATIBILITY (1970) (1)
Resistance of erythrocytes to isoantibody effects in vivo and in vitro. (1965) (1)
Characteristics of B Lymphocytes and Their Mechanism of Activation (1976) (1)
Activation and regulation of immunoglobulin synthesis in malignant B cells/ David Baltimore ... [et al.] (1979) (1)
Effects of human granulocytes and lymphocytes on human fibroblasts in vitro. (1968) (1)
Genetics of the anti-dextran B512 and the autoanti-idiotypic response: Codominant expression in F1 hybrids and dichotomy of response and allotype-linked idiotype (2005) (1)
Selective inability of LPS-activated B lymphocytes to produce antibodies against autologous and allogeneic MHC class I antigens. (1994) (1)
Growth inhibition by interaction between allogeneic cells. A model for the elimination of incompatible cells. (1966) (1)
Role of Antigen in the Regulation of the Immune Response to Dextran B512 (1984) (1)
The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction (2004) (1)
[What is the significance of the immune system in the etiology of cancer?]. (1976) (1)
Molecular aspects of V genes (1977) (1)
Ionophore A23-187 induces responses to TCGF in mouse lymphocytes. (1984) (1)
The 100th volume of Immunological Reviews. (1987) (1)
Induction of DNA synthesis in lymphocytes from ALG-treated patients. (1970) (1)
The immune system as a model for cellular maturation and differentiation. (1973) (1)
Genetics of the Immune Response (2012) (0)
Transplantation of Ovaries (1971) (0)
No histocompatibility requirements for macrophage-lymphocyte interactions in the primary immune antibody response to sheep erythrocytes in vitro (1976) (0)
Immunology in Scandinavia. (2001) (0)
[New principles in the origin of genes clarify antibody variability]. (1980) (0)
Immunological and Immunogenetic Aspects of Tumor Transplantation (Part 3 of 3) (1965) (0)
TRIGGERING AND TOLERANCE (1980) (0)
[Selection of donors and recipients for homotransplantation]. (1968) (0)
Sensitivity of thymus independent immune responses to cyclosporin a (1982) (0)
CHAPTER 22 – POLYCLONAL B-CELL ACTIVATORS IN THE ANALYSIS OF IMMUNODEFICIENCY STATES1 (1979) (0)
SEB induces a T cell dependent polycional B cell activation in mice (1997) (0)
Survival of mouse erythrocytes in histoincompati‐ble recipients (1964) (0)
Theantibody spectruminindividuals withdefect expression ofHLA class II andtheLFA-1glycoprotein family genes (1988) (0)
The Degree of Clonal Elimination in Immunological Tolerance and Regulation of Heavy Chain Class Switches (1983) (0)
[Epidemiology and mercury]. (2001) (0)
Isoantibody-induced cellular resistance to immune haemolysis in vivo and in vitro (1964) (0)
MHC and MLS determinants. (1981) (0)
Role of antigen and, antibody in the regulation of the immune response (2008) (0)
[Immunological reactions of the lymphatic system]. (1970) (0)
GENERAL DISCUSSION - SESSION II: B CELL TOLERANCE (1974) (0)
[The immunological reactions of the lymphatic system]. (1970) (0)
Mechanism of b lymphocyte tolerance to a thymus independent antigen (1982) (0)
β[2]-microglobulin and HL-A antigen (1974) (0)
Anti-alpha 1-6 epitope, specificity of a T-cell hybrid-secreted factor: affinity- and ion-exchange chromatographic separation. (1988) (0)
Immunological and Immunogenetic Aspects of Tumor Transplantation (Part 2 of 3) (1964) (0)
ACTIVATED BY LIPOPOLYSACCHARI DE TO SYNTHESIZE ANTIBODIES AGAINST THE TOLEROGEN (1976) (0)
GENERAL DISCUSSION: MITOGEN-INDUCED B-CELL ACTIVATION. II. (1979) (0)
Do suppressor T cells exist (1987) (0)
Immunologic surveillance revisited. (1979) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Göran Möller?

Göran Möller is affiliated with the following schools:

Göran Möller's Academic­Influence.com Rankings